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(Schroeder et al., 2008) is highly ex-
pressed in inner supporting cells and the
calcium transient activated by ATP gener-
ates a substantial chloride efflux current in
these cells. Surprisingly, the burst firing of
inner hair cells is not due to the direct acti-
vation of purinergic receptors on hair cells
but is instead due to the ATP-triggered
calcium signals and chloride efflux in the
glial-like supporting cells. Burst firing in
hair cells is lost when expression of
TMEM16a channels is reduced or elimi-
nated in the inner supporting cells. The
clue to the mechanism came from the
similarities with observations between
fluid secretion from epithelial cells and
the shape change of the inner supporting
cells. ATP triggers crenation, the term for
osmosis-induced cell shrinkage, in inner
supporting cells due to the efflux of water
associated with the substantial chloride
efflux observed after TMEM16a activa-
tion. In exocrine epithelia of various or-
gans the efflux of chloride via TMEM16a
(Huang et al., 2012) causes the concurrent
efflux of K+ and water to maintain ionic
and osmotic gradients (Frizzell and Han-
rahan, 2012). Wang et al. show that the1308 Cell 163, December 3, 2015 ª2015 Elseefflux of K+ from inner supporting cells is
sufficient to increase extracellular to
approximately 12 mM (Wang et al.,
2015). This change in external [K+] is
both required and sufficient for inner sup-
porting cells to trigger calcium spike
bursting in inner hair cells.
In the central nervous system, astro-
cytes are the glial cells that keep extracel-
lular [K+] within a very narrow range
around 3 mM (Kofuji and Newman,
2004). Increases of several mM are gener-
ated by neuronal activity and seizures are
characterized by external [K+] up to 13-
15 mM. K+ efflux could occur from astro-
cytes due to spatial buffering by glial
networks when K+ diffuses through astro-
cytes from regions of high to low extracel-
lular [K+] (Kofuji and Newman, 2004).
Astrocytes also have a GABA-activated
Cl current, first proposed by Bormann
and Kettenmann (Bormann and Ketten-
mann, 1988) to generate K+ efflux to
depolarize neurons. The discovery of the
mechanism underlying K+ efflux from in-
ner supporting cells and the profound
impact on hair cell calcium bursting will
certainly lead to investigations on thevier Inc.impact of Cl and associated K+ effluxes
from astrocytes in regulating neuronal cir-
cuit excitability in the developing central
nervous system.
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T helper 17 (Th17) cells are critical for host defense but can also drive autoimmunity. This divergent
behavior is explored by Gaublomme et al. and Wang et al., who identify inflammation-associated
genes by measuring gene expression in nearly 1,000 individual Th17 cells and show that CD5L
affects the expression of pro-inflammatory genes by altering lipid synthesis.T helper (Th) cells are workhorses of
adaptive immunity, which as their name
implies, help other immune cells respond
appropriately to pathogens. The Th para-
digm began with two lineages: Th1 cells
that respond to intracellular pathogens
and Th2 cells that respond to extracellular
parasites. A third lineage, Th17 cells, wasidentified more recently (Harrington et al.,
2006; Stockinger and Veldhoen, 2007;
Toh and Miossec, 2007). As various
groups began to map the mechanisms
that specified their development, the het-
erogeneity of Th17 cells began to be
appreciated (Ghoreschi et al., 2010).
While originally the role of Th17 cells inautoimmunity was emphasized, it has
become clear that non-pathogenic Th17
cells in the gut are controlled by the mi-
crobiome and are critical for intestinal
barrier function (Littman and Rudensky,
2010). However, the molecular mecha-
nisms underlying these divergent behav-
iors remain relatively poorly understood.
Figure 1. Measuring Gene Expression in
Single Th17 Cells Reveals a Metabolic
Switch for Pathogenicity
Th17 cells are functionally heterogeneous, with
some critical for host defense (non-pathogenic) and
others driving autoimmunity (pathogenic). Gau-
blomme et al. (2015) characterize the genetic basis
of this heterogeneity bymeasuring gene expression
in individual Th17 cells. They find two distinct
modules of genes that correlate with pathogenicity:
a pro-inflammatory module that correlates posi-
tively with inflammatory genes and a regulatory
module that correlates negatively with these genes.
Wang et al. (2015) show that CD5L is expressed in
non-pathogenic cells, where it negatively regulates
pro-inflammatory genes. CD5L acts as a metabolic
switch that alters the balance of lipid saturation and
affects the availability of ligands for RORgt, the
master transcription factor of Th17 cells. Although
the mechanism is not yet clear, the effect of CD5L
on lipid metabolism reduces RORgt binding at the
pathogenic IL-23r and IL-17 genes and increases
binding at the protective IL-10 gene.Understanding this issue is not simply an
intriguing intellectual exercise but has
direct clinical relevance with respect to
the divergent consequences of targeting
IL-17 in various diseases ranging from
psoriasis to inflammatory bowel disease.The heterogeneity of Th17 function also
points to the fundamental question of how
to define a cell type. The operating defini-
tion for Th17 cells is IL-17 production, but
this criterion does not distinguish patho-
genic from non-pathogenic cells. Cellular
heterogeneity is an issue that immunolo-
gists and cell biologists in general have
confronted for years. Flow cytometry
revolutionized immunology by allowing
high-throughput counting and purifying
of subpopulations based on cell-surface
markers. Newmethods to measure genes
expressed in single cells are a powerful
complement to flow cytometry, enabling
transcript-based sorting of cellular het-
erogeneity.
In this issue, single-cell measurements
of gene expression are used in conjunc-
tion with traditional genetics and immu-
nology to identify regulators of Th17 cells.
Gaublomme et al. (2015) measure the
genes expressed in nearly 1,000 individ-
ual Th17 cells generated in vitro or purified
from an in vivo model of multiple sclerosis
to relate their expression pattern to Th17
pathogenesis. This comprehensive sur-
vey of 1,000 Th17 ‘‘individuals’’ iden-
tifies two distinct modules of genes: a
pro-inflammatory module whose expres-
sion levels positively correlated with
known pro-inflammatory genes and a reg-
ulatory module whose expression levels
negatively correlate with these genes.
Furthermore, these new measurements
reveal a set of genes, including potential
regulators, that otherwise ranked poorly
in previous bulk population studies.
Among newly identified potential regula-
tors, Wang et al. (2015) show that CD5L
acts as a metabolic switch to link the
metabolic state of Th17 cells to its master
regulator RORgt (Littman and Rudensky,
2010). Together, these studies convinc-
ingly demonstrate the power of single-
cell genomics to characterize cellular
heterogeneity and unveil key molecules
contributing to differences in cell state
and function (Figure 1).
It is interesting to note that, in Wang
et al.’s analysis, CD5L has a counterintu-
itive pattern of expression. Although its
expression level correlates with the
pro-inflammatory module, the gene was
expressed only in non-pathogenic cells.
This pattern suggests that it is a negative
regulator. The authors confirm the role
of CD5L in vivo by showing that CD5LCell 163, Dexpression level correlates with the
severity of experimental autoimmune
encephalomyelitis symptoms. The most
fascinating aspect of this story comes
next, when they ask how CD5L works.
Previous work has shown that CD5L is
secreted by macrophages and endocy-
tosed by adipocytes, where it directly
binds fatty acid synthase (Kurokawa
et al., 2010). This led the authors to hy-
pothesize that CD5L affects lipid biosyn-
thesis in Th17 cells. In fact, the authors
show that CD5L alters the balance of
polyunsaturated and saturated fatty
acids, specifically affecting two meta-
bolic genes, cyp51 and sc4mol, which
synthesize endogenous ligands for
RORgt—the master transcription factor
in Th17 cells. CD5L-deficient mice
have increased RORgt binding at the
IL-17 and IL-23r loci (both pro-inflamma-
tory genes) and decreased binding at
IL-10 (a regulatory gene). They also
show that altering the balance of lipid
saturation mimics the effect of CD5L
deficiency.
This new link from lipid metabolism
through transcription factor binding to
Th17 pathogenicity is tantalizing but
also raises the obvious question of spec-
ificity. How can the availability of lipid
ligands for RORgt selectively increase its
binding in some parts of the genome
and reduce its binding in others?
Other proteins are likely involved, as tran-
scription factor binding is often a combi-
natorial affair, but the precise mechanism
of specificity is an exciting question to
explore further. The authors clearly
demonstrate the importance of CD5L in
controlling Th17 function, but how is
CD5L itself controlled? A puzzle in the
new findings suggests that this mecha-
nism is complicated: Stat3 promotes
CD5L expression, and IL-23 promotes
Stat3 expression, yet somehow IL-23
suppresses CD5L. Elucidating how
CD5L expression is regulated is another
open avenue of work.
In summary, Gaublomme and Wang
demonstrate the power of single-cell
measurements of gene expression to
map the genetic basis of Th17 functional
heterogeneity. Measuring the genes ex-
pressed in single cells is becoming
cheaper and of higher throughput and is
already proving valuable for surveying
cell diversity in complex tissues like theecember 3, 2015 ª2015 Elsevier Inc. 1309
retina (Macosko et al., 2015). In addition
to measuring transcriptional output,
new methods have also been developed
to characterize transcriptional regula-
tion by measuring methylated DNA,
accessible chromatin, modified histones,
and chromatin conformation in single
cells (Schwartzman and Tanay, 2015).
Of course, technical hurdles remain.
Measuring genes expressed in single
cells is noisy, and existing methods suffer
from low sensitivity. Methods to charac-
terize chromatin in single cells are even
less mature and face harder limits on the
dynamic range of their measurements.
However, if history is a guide, these
methods will be improved rapidly and
together form a suite of tools to systemat-1310 Cell 163, December 3, 2015 ª2015 Elseically discover new cell types andmap the
genetic control of their phenotype and
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The fidelity of the intestinal barrier is critical to maintaining a healthy relationship between the
immune system and the microbiota. Levy et al. and Nowarski et al. reveal how microbiota-derived
metabolites modulate the activation of the inflammasome to influence the expression of the cyto-
kine IL-18, intestinal barrier function, and intestinal inflammation.The mucosal immune system has a
complex task, as it must be vigilant to
pathogens while maintaining cordial
relations with the relatively benign
commensal microbiota. To complicate
matters, inflammation in the intestine
can allow the outgrowth of aggressive
members of the microbiota, blurring the
lines between ‘‘pathogens’’ and ‘‘com-
mensals’’ and contributing to autoinflam-
matory conditions such as inflammatory
bowel disease (Dalal and Chang, 2014).
A primary mechanism of immune homeo-
stasis in the gut is to limit the interaction
with themicrobiota via the physical barrier
made of the intestinal epithelial cells
(IECs), anti-microbial proteins, and the
mucus, produced by goblet cells (Hooper
and Macpherson, 2010). The inflamma-
some, a macromolecular structure thatsupports the post-translational produc-
tion of the cytokines IL-1b and IL-18,
plays a critical role in supporting the intes-
tinal barrier. As a result, mice deficient in
inflammasome function and IL-18 pro-
duction develop an invasive dysbiotic mi-
crobiota that exacerbates pathology in
mouse models of chemically induced co-
litis (Elinav et al., 2013). Two papers in this
issue of Cell now better elucidate how
the inflammasome and microbiota
interact via sensing of metabolites to
induce IL-18 expression, modulate intes-
tinal barrier function, and intestinal inflam-
mation (Levy et al., 2015; Nowarski et al.,
2015).
Previous studies on mice deficient in
key components of the inflammasome
have indicated that this structure may
support goblet cell secretion and there-fore intestinal barrier function, indepen-
dent of the production of IL-18 (Wlodar-
ska et al., 2014). Levy et al. (2015) now
extend these findings to show that, at
steady state, signals from the microbiota
are necessary for inflammasome activa-
tion, IL-18 production, and the expression
of certain anti-microbial proteins (AMPs).
Critically, one of these AMPs, Ang4, is suf-
ficient to restore microbial diversity,
providing an explanation of how IL-18
supports the intestinal barrier and why
abrogation of IL-18 may lead to
commensal dysbiosis (see Figure 1). In
contrast, during instances of acute
inflammation, IL-18 may exacerbate dis-
ease. Using a series of genetic tools to
parse the role of IL-18 during chemically
induced colitis, Nowarski et al. (2015)
show that IL-18 signaling specifically
